[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

SE9401406L - Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma - Google Patents

Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma

Info

Publication number
SE9401406L
SE9401406L SE9401406A SE9401406A SE9401406L SE 9401406 L SE9401406 L SE 9401406L SE 9401406 A SE9401406 A SE 9401406A SE 9401406 A SE9401406 A SE 9401406A SE 9401406 L SE9401406 L SE 9401406L
Authority
SE
Sweden
Prior art keywords
pct
pharmaceutical products
cure
preparation
products
Prior art date
Application number
SE9401406A
Other languages
Unknown language ( )
English (en)
Other versions
SE9401406D0 (sv
SE513624C2 (sv
Inventor
Somlyai Gabor
Original Assignee
Hyd Kutato Fejlesztoe Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hyd Kutato Fejlesztoe Kft filed Critical Hyd Kutato Fejlesztoe Kft
Publication of SE9401406D0 publication Critical patent/SE9401406D0/sv
Publication of SE9401406L publication Critical patent/SE9401406L/sv
Publication of SE513624C2 publication Critical patent/SE513624C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE9401406A 1991-10-31 1994-04-25 Farmaceutiska produkter innehållande en låg halt av denterium, förfarande för framställning därav samt användning av produkterna i samband med behandling av tumörsjukdomar SE513624C2 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU913437A HU208084B (en) 1991-10-31 1991-10-31 Process for producing compositions suitable for curing tumorous diseases
PCT/HU1992/000036 WO1993008794A1 (en) 1991-10-31 1992-09-28 Pharmaceutical products for curing tumorous diseases and process for preparing same

Publications (3)

Publication Number Publication Date
SE9401406D0 SE9401406D0 (sv) 1994-04-25
SE9401406L true SE9401406L (sv) 1994-06-07
SE513624C2 SE513624C2 (sv) 2000-10-09

Family

ID=10964023

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9401406A SE513624C2 (sv) 1991-10-31 1994-04-25 Farmaceutiska produkter innehållande en låg halt av denterium, förfarande för framställning därav samt användning av produkterna i samband med behandling av tumörsjukdomar

Country Status (22)

Country Link
US (1) US5855921A (sv)
JP (1) JP3569916B2 (sv)
KR (1) KR100253874B1 (sv)
CN (1) CN1045162C (sv)
AT (1) AT402692B (sv)
BE (1) BE1006186A3 (sv)
CA (1) CA2122612C (sv)
CH (1) CH685282A5 (sv)
CZ (1) CZ282379B6 (sv)
DE (1) DE4232465B4 (sv)
DK (1) DK170832B1 (sv)
ES (1) ES2077530B1 (sv)
FI (1) FI114010B (sv)
FR (1) FR2683148B1 (sv)
GB (1) GB2276086B (sv)
HU (1) HU208084B (sv)
IT (1) IT1255390B (sv)
LU (1) LU88175A1 (sv)
NL (1) NL194664C (sv)
NO (1) NO307031B1 (sv)
SE (1) SE513624C2 (sv)
WO (1) WO1993008794A1 (sv)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09511129A (ja) * 1994-01-06 1997-11-11 ハーイデー クタトー−フェイレステー カーエフテー 病気予防のための食品及びその製造方法
HU214593B (hu) * 1994-03-23 1998-06-29 HYD Kutató-Fejlesztő Kft. Kozmetikai, higiéniai, valamint szépség- és testápoló készítmények és eljárás azok előállítására
DE4427690A1 (de) * 1994-08-04 1996-02-08 Bogdahn Ulrich Prof Deuterium enthaltende pharmazeutische Zusammensetzung als Zytostatikum oder Tumor-Therapeutikum
HU217418B (hu) * 1995-04-20 2000-01-28 László Kótai Kémiai eljárás alacsony deutériumtartalmú víz előállítására
RU2083210C1 (ru) * 1995-09-13 1997-07-10 Николаева Ирина Сергеевна Средство для профилактической, поддерживающей и восстановительной терапии развивающихся при старении и/или под воздействием патогенных факторов патологий, связанных с дистрофическим и дегенеративными изменениями органов и тканей
US6444238B1 (en) 2000-03-10 2002-09-03 General Cosmetics Corporation Pain relief composition and method of relieving pain
HU226984B1 (en) * 2001-12-12 2010-04-28 Hyd Kutato Fejlesztoe Kft Medical and food products for treating diabetes mellitus and process for producing thereof
ATE412906T1 (de) * 2002-02-12 2008-11-15 Univ California Nichtinvasive messung der biosynthese- und abbaugeschwindigkeiten biologischer moleküle, die einer direkten probenahme unzugänglich oder nicht leicht zugänglich sind, durch einbau einer markierung in metabolische derivate und katabole produkte
AU2003256819B2 (en) 2002-07-30 2009-11-12 The Regents Of The University Of California Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
AU2002321678A1 (en) * 2002-09-09 2004-03-29 Boros Béla Oxygen-enriched water, treated within a magnetic field and heavy water
JP4610337B2 (ja) * 2002-09-13 2011-01-12 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 抗アテローム発生の指標としてのｉｎｖｉｖｏでの逆コレステロール輸送速度の測定方法
SG152922A1 (en) 2002-11-04 2009-06-29 Univ California Deuterated glucose or fat tolerance tests for high-throughput measurement of the metabolism of sugars or fatty acids in the body
JP2004315487A (ja) * 2003-04-17 2004-11-11 Internatl Scient:Kk 重水素減少水（スーパーライトウォーター）を原料とするスポーツドリンクの飲用による筋肉増強、及び製造方法。
RO120171B1 (ro) * 2003-05-23 2005-10-28 Ioan Nedelcu Produse cosmetice şi pentru igienă, procedeu de obţinere şi procedeu de aplicare a acestora
US7262020B2 (en) * 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
RO120505B1 (ro) * 2003-08-13 2006-02-28 Institutul Oncologic Profesor Dr. Al. Trestioreanu Metodă pentru stabilirea in vivo la animale de experienţă, a concentraţiei eficiente de apă sărăcită în deuteriu pentru tratamentul cancerului
US20050202406A1 (en) * 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
WO2005070438A1 (en) * 2004-01-23 2005-08-04 Igor Anatolievich Pomytkin Pharmaceutical composition comprising water depleted of heavy isotopes 0-17 and 0-18
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
US20050226825A1 (en) * 2004-04-13 2005-10-13 Giampapa Vincent C Topical composition for preventing and treating skin damage caused by UV light exposure
WO2005117566A1 (ja) * 2004-06-03 2005-12-15 Kunihiro Seki 低重水素濃度食品の生産装置
RO121676B1 (ro) * 2004-08-18 2008-02-28 Institutul Oncologic "Prof.Dr. Al. Trestioreanu" Metodă de creştere a toleranţei organismului la tratamentul cu citostatice
MX2007009544A (es) 2005-02-08 2008-03-19 Woodford Associates Ltd Bebida sin alcohol enriquecida con 1h2 16o.
PT1846546E (pt) * 2005-02-08 2011-07-06 Woodford Associates Ltd Bebida alcoólica enriquecida com 1h2 16o
EP1855762B1 (en) * 2005-03-05 2012-05-30 Sergey Pavlovich Soloviev Cosmetic composition enriched with 1h216o
WO2006098651A1 (en) * 2005-03-11 2006-09-21 Vada Consulting Limited Compositions for disinfecing inanimate surfaces
JP2008533005A (ja) * 2005-03-11 2008-08-21 ヴァーダ コンサルティング リミテッド 生物学的活性物質の皮内的、経皮的又は経粘膜的送達のための方法
EP1855699B1 (en) * 2005-03-11 2012-08-15 Sergey Pavlovich Soloviev Light pharmaceutical water and therapeutic compositions and methods thereof
RU2275920C1 (ru) * 2005-04-01 2006-05-10 Игорь Анатольевич Помыткин Способ лечения новообразований
US20060251576A1 (en) * 2005-05-03 2006-11-09 The Regents Of The University Of California Methods for measuring cholesterol metabolism and transport
TW200711660A (en) * 2005-06-10 2007-04-01 Univ California Monitoring two dimensions of diabetes pathogenesis separately or concurrently (insulin sensitivity and beta-cell sufficiency): uses in diagnosis, prognosis, assessment of disease risk, and drug development
EP1971350A1 (en) * 2005-12-12 2008-09-24 VADA Consulting Limited Method of treating metabolic syndrome
WO2007069933A1 (en) * 2005-12-12 2007-06-21 Vada Consulting Limited Method for decreasing postprandial glucose excursion
WO2007069932A1 (en) * 2005-12-12 2007-06-21 Vada Consulting Limited Method for suppressing appetite and food intake
HUP0900231A2 (hu) * 2009-04-16 2010-11-29 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Allergiás betegségek kezelésére, gyógyítására alkalmas készítmények és eljárás azok elõállítására
DE202009018629U1 (de) 2009-04-21 2012-06-11 Renate Rohlf Gesundheitsförderndes flüssiges Nahrungsmittel
US8658236B2 (en) * 2009-08-21 2014-02-25 Deuteria Beverages, Llc Alcoholic compositions having a lowered risk of acetaldehydemia
WO2012166459A1 (en) * 2011-05-27 2012-12-06 Bristol-Myers Squibb Company Tripeptides incorporating deuterium as inhibitors of hepatitis c virus
HUP1100290A2 (en) * 2011-06-01 2012-12-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Combination compositions for the treatment of proliferative diseases
WO2013036885A1 (en) 2011-09-08 2013-03-14 The Regents Of The University Of California Metabolic flux measurement, imaging and microscopy
US20140353486A1 (en) 2011-12-07 2014-12-04 Glaxosmithkline Llc Methods for determining total body skeletal muscle mass
HUP1200552A2 (en) 2012-09-21 2014-04-28 Hyd Rakkutato Es Gyogyszerfejlesztoe Kft Pharmaceutical compositions for the treatment of high blood pressure
US20150313266A1 (en) * 2012-12-03 2015-11-05 Igor Anatolievich Pomytkin Food for the dietary management of burnout
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo
CN103462830A (zh) * 2013-09-03 2013-12-25 大连世纪新源技术开发有限公司 超轻水多肽化妆品及其制备方法
EP3160590B1 (en) * 2014-06-30 2018-04-25 Mitochondrial Substrate Invention Limited Nutrients solutions for enhancement of cognitive function
RU2601046C1 (ru) * 2015-07-29 2016-10-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный университет" (ФГБОУ ВПО "КубГУ") Способ снижения содержания дейтерия в пищевых сельскохозяйственных культурах
WO2018053578A1 (en) * 2016-09-21 2018-03-29 Ambrosios Kambouris Isotopic compositions
US20200368686A1 (en) * 2018-01-02 2020-11-26 Botanical Water Technologies Ip Ltd Isotopic compositions ii
WO2019174659A1 (de) 2018-03-15 2019-09-19 Karl Bau Gmbh Verfahren und anordnung zur herstellung von deuterium reduziertem wasser
CN112811559A (zh) * 2020-12-30 2021-05-18 江苏奥特泉超轻水饮料有限公司 一种低氘氢水及其制备方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3807960A (en) * 1969-08-04 1974-04-30 V Thayer Apparatus for enrichment of deuterium between water and hydrogen sulfide by countercurrent mass transfer
JPS53107408A (en) * 1977-02-28 1978-09-19 Yamanouchi Pharmaceut Co Ltd Micellar preparation for rectal infusion
JPS56141822A (en) * 1980-04-07 1981-11-05 Hitachi Ltd Method for separating and recovering hydrogen isomer
US4411798A (en) * 1980-05-27 1983-10-25 Standard Oil Company Process for separating D2 O from H2 O using surfactant systems
FR2552324B1 (fr) * 1983-09-23 1985-11-22 Ionescu Pantelimon Dumitru Eau anticancereuse, procede pour sa realisation, outillage pour sa conservation, et methode pour le traitement du cancer
GB8705780D0 (en) * 1987-03-11 1987-04-15 Norsk Hydro As Anticancer compounds
DE3717883A1 (de) * 1987-05-27 1988-12-15 Schiwa Gmbh Verfahren und anordnung zur herstellung von physiologischen loesungen
EP0335918A1 (en) * 1987-08-07 1989-10-11 Mallinckrodt Diagnostica (Holland) B.V. Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound
IL85312A (en) * 1988-02-03 1991-08-16 Israel State Injectable pharmaceutical compositions having improved stability
US4931154A (en) * 1989-07-17 1990-06-05 Southwestern Analytical Chemicals, Inc. Production of metal borohydrides and organic onium borohydrides
US5223269A (en) * 1989-08-31 1993-06-29 Andrejs Liepins Methods and composition for the treatment of hypertension

Also Published As

Publication number Publication date
CZ282379B6 (cs) 1997-07-16
HU208084B (en) 1993-08-30
US5855921A (en) 1999-01-05
FI941979A (sv) 1994-06-29
JP3569916B2 (ja) 2004-09-29
NO307031B1 (no) 2000-01-31
CN1045162C (zh) 1999-09-22
FR2683148A1 (fr) 1993-05-07
CN1071836A (zh) 1993-05-12
KR100253874B1 (ko) 2000-04-15
FI114010B (sv) 2004-07-30
SE9401406D0 (sv) 1994-04-25
BE1006186A3 (fr) 1994-06-07
CA2122612C (en) 2003-02-04
CH685282A5 (de) 1995-05-31
GB9408654D0 (en) 1994-07-20
FR2683148B1 (fr) 1994-09-09
ITMI922233A1 (it) 1994-03-28
NL9220026A (nl) 1994-09-01
ATA902992A (de) 1996-12-15
DE4232465B4 (de) 2008-11-06
AT402692B (de) 1997-07-25
NO941590L (sv) 1994-06-23
SE513624C2 (sv) 2000-10-09
ES2077530B1 (es) 1996-07-01
GB2276086B (en) 1995-09-27
IT1255390B (it) 1995-10-31
WO1993008794A1 (en) 1993-05-13
NL194664C (nl) 2002-11-04
FI941979A0 (sv) 1994-04-29
ES2077530A1 (es) 1995-11-16
NL194664B (nl) 2002-07-01
LU88175A1 (fr) 1993-03-15
HU913437D0 (en) 1992-01-28
GB2276086A (en) 1994-09-21
CZ102094A3 (en) 1994-12-15
ITMI922233A0 (it) 1992-09-28
JPH08501275A (ja) 1996-02-13
CA2122612A1 (en) 1993-05-13
KR930007461A (ko) 1993-05-20
NO941590D0 (sv) 1994-04-29
DE4232465A1 (de) 1993-05-06
DK170832B1 (da) 1996-02-05

Similar Documents

Publication Publication Date Title
SE9401406L (sv) Farmaceutiska produkter för att bota tumörsjukdomar samt förfarande för framställning av desamma
DE59009462D1 (de) Implantierbare Vorrichtung zur dosierten Abgabe von Medikamenten in den menschlichen Körper.
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
ATE185268T1 (de) Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin
NZ504026A (en) Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C
YU209288A (en) Process for producing compound for treating, which contains azelastin for use in nose and/or eye
DE69426669D1 (de) Tierarzneimittel, das einen protonenpumpeninhibitor enthält
MY107088A (en) Plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release,process for the production of the plaster and use thereof
FI891774A0 (sv) Förfarande för framställning av en administrerings- och/eller doseringsform av ett läkemedel
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
DE3751036D1 (de) Durch Carnitin dirigierte pharmazeutische Substanzen und ihre Verwendung zur Herstellung eines Arzneimittels zur Behandlung von Muskelerkrankungen.
DE3850778D1 (de) Verwendung von tetracycline zur herstellung eines arzneimittels zum herabsetzen des augendrucks.
DE3481057D1 (de) 2-sulfamoylbenzo(b)thiophen-derivate, ihre herstellung und pharmazeutische zubereitung zur behandlung von erhoehtem augeninnendruck.
FI891357A (sv) Förfarande för framställning av salicylsyraderivathaltigt ämne mot mjällbildande hudsjukdomar
DE58903659D1 (de) Pharmazeutische zubereitung zur behandlung entzuendeter nasenschleimhaeute.
DE68928415D1 (de) Verfahren und zusammensetzungen zur verabreichung von lipophilen heilmitteln in einer dosierung nach der gewünschten wirkung
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
IT8519907A0 (it) Prodotto farmaceutico cosmetico, in particolare per la cura di acne e seborrea.
ATE183390T1 (de) Verwendung einer kombination von antineoplastonen zur herstellung eines arzneimittels zur behandlung der neurofibromatose
ATE69949T1 (de) Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE69300037D1 (de) Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria.
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
SE9101341D0 (sv) New medicinal use
GB2019720A (en) S-adenosyl-L-homocysteine and salts thereof for use in therapy
ATE137968T1 (de) Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen

Legal Events

Date Code Title Description
NUG Patent has lapsed